MedTrace Logo

Efficacy and Safety of Beta-glucan Supplement in Chronic Obstructive Pulmonary Disease Patients

NCT05878834 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2023-05-30

No results posted yet for this study

Summary

The objectives of this study are to evaluate Efficacy and safety of beta-glucan supplement in chronic obstructive pulmonary disease patients.

Conditions

  • Chronic Obstructive Pulmonary Disease Patients

Interventions

DIETARY_SUPPLEMENT

Beta-glucan supplement group

Take 1 capsule 1 time per day for 12 weeks.

DIETARY_SUPPLEMENT

Placebo group

Take 1 capsule 1 time per day for 12 weeks.

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Pornanong Aramwit, Professor · Chulalongkorn University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-25
Primary Completion
2023-11-30
Completion
2023-12-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05878834 on ClinicalTrials.gov